Clinical trial · Observational
The Relationship Between Adipokines, Obesity and Insulin Resistance in Women With Polycystic Ovarian Syndrome
Evaluation of Adipokines ( Ghrelin, Resistin and Adiponectin), in Egyptian Women With Polycystic Ovary Syndrome
NCT02869750CI-TRIAL-00035102completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate possible clinical effects of adipokines , ( ghrelin, resistin and adiponectin), in obese and non-obese patients with polycystic ovary syndrome (PCOS).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovarian Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (4)
- label
- Obese PCOS
- description
- PCOS patients with BMI more than 25 kg/m2
- label
- Lean PCOS
- description
- PCOS patients with BMI less than 25 kg/m2
- label
- PCOS with normal HOMA2-1R
- description
- PCOS without Insuline resistance
- label
- PCOS with elevated HOMA2-IR
- description
- PCOS with Insuline resistance
Primary outcomes (3)
- measure
- serum ghrelin level
- timeFrame
- 24 hours
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Females with PCOS in child bearing age who presented at reproductive and endocrinology clinics at Ain Shams University Maternity Hospital Exclusion Criteria: * Known androgen secreting tumor. * PCO on ovarian stimulation medications * PCO with any other medical illness.
References
Publications (0)
Data not yet available
No reference posted for this study.